Home LiteratureArticle Details
PMID: 16213784 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Avian influenza A (H5N1).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology ·Vol. 35 ·No. 1 ·2006-01-00 ·Pages 2-13

de Jong MD, Hien TT

Abstract

Since their reemergence in 2003, highly pathogenic avian influenza A (H5N1) viruses have reached endemic levels among poultry in several southeast Asian countries and have caused a still increasing number of more than 100 reported human infections with high mortality. These developments have ignited global fears of an imminent influenza pandemic. The current knowledge of the virology, clinical spectrum, diagnosis and treatment of human influenza H5N1 virus infections is reviewed herein.

MeSH Terms
Animals Antiviral Agents/therapeutic use Birds/virology Humans Influenza A Virus, H5N1 Subtype/pathogenicity Influenza in Birds/epidemiology,transmission,virology Influenza, Human/diagnosis,drug therapy,epidemiology,virology Poultry/virology Zoonoses/transmission,virology
Chemicals
Antiviral Agents
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
de Jong Menno D
Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho Chi Minh City, Viet Nam. mddejong@hcm.vnn.vn
Hien Tran Tinh
References (97)
97 references, click to expand
  1. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.
    Virology. 1983 Jun;127(2):361-73 PMID: 6868370
  2. Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea.
    J Virol. 2005 Mar;79(6):3692-702 PMID: 15731263
  3. Transmissibility of 1918 pandemic influenza.
    Nature. 2004 Dec 16;432(7019):904-6 PMID: 15602562
  4. Avian influenza--a challenge to global health care structures.
    N Engl J Med. 2004 Dec 2;351(23):2363-5 PMID: 15575048
  5. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.
    Lancet. 1998 Feb 14;351(9101):467-71 PMID: 9482437
  6. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Antimicrob Agents Chemother. 2001 Oct;45(10):2723-32 PMID: 11557461
  7. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.
    J Virol. 1999 Feb;73(2):1146-55 PMID: 9882316
  8. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?
    Lancet. 2002 Dec 7;360(9348):1831-7 PMID: 12480361
  9. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.
    Virology. 1997 Jun 23;233(1):224-34 PMID: 9201232
  10. Are we ready for pandemic influenza?
    Science. 2003 Nov 28;302(5650):1519-22 PMID: 14645836
  11. Failure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions.
    Infect Immun. 1982 Nov;38(2):530-5 PMID: 6292104
  12. Influenza A H5N1 replication sites in humans.
    Emerg Infect Dis. 2005 Jul;11(7):1036-41 PMID: 16022777
  13. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.
    J Virol. 2005 Mar;79(5):2814-22 PMID: 15709000
  14. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential.
    J Virol. 1998 Sep;72(9):7367-73 PMID: 9696833
  15. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center.
    Clin Infect Dis. 2005 Jan 15;40(2):e16-8 PMID: 15655735
  16. Replication of avian influenza viruses in humans.
    Arch Virol. 1991;119(1-2):37-42 PMID: 1863223
  17. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.
    Virology. 1994 Nov 15;205(1):17-23 PMID: 7975212
  18. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.
    J Gen Virol. 2005 Feb;86(Pt 2):423-433 PMID: 15659762
  19. Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001.
    J Virol. 2003 Mar;77(6):3816-23 PMID: 12610156
  20. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
    Lancet. 1998 Feb 14;351(9101):472-7 PMID: 9482438
  21. Potential for transmission of avian influenza viruses to pigs.
    J Gen Virol. 1994 Sep;75 ( Pt 9):2183-8 PMID: 8077918
  22. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.
    Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1356-61 PMID: 14745020
  23. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia.
    Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10682-7 PMID: 16030144
  24. Vaccination strategies for an influenza pandemic.
    J Infect Dis. 2005 Apr 15;191(8):1207-9 PMID: 15776363
  25. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998.
    J Infect Dis. 2002 Apr 15;185(8):1005-10 PMID: 11930308
  26. Latex agglutination test for monitoring antibodies to avian influenza virus subtype H5N1.
    J Clin Microbiol. 2005 Apr;43(4):1953-5 PMID: 15815030
  27. Avian H5N1 influenza in cats.
    Science. 2004 Oct 8;306(5694):241 PMID: 15345779
  28. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong.
    Virology. 1999 Aug 15;261(1):15-9 PMID: 10484749
  29. Influenza-associated encephalopathy in Japan.
    Semin Pediatr Infect Dis. 2002 Apr;13(2):79-84 PMID: 12122956
  30. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.
    Science. 2004 Mar 19;303(5665):1866-70 PMID: 14764887
  31. Human illness from avian influenza H7N3, British Columbia.
    Emerg Infect Dis. 2004 Dec;10(12):2196-9 PMID: 15663860
  32. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans.
    J Virol. 2000 Jul;74(14):6592-9 PMID: 10864673
  33. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.
    Nature. 1983 Jul 7-13;304(5921):76-8 PMID: 6191220
  34. The evolution of H5N1 influenza viruses in ducks in southern China.
    Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10452-7 PMID: 15235128
  35. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.
    J Virol. 1995 Apr;69(4):2075-81 PMID: 7884853
  36. Atypical avian influenza (H5N1).
    Emerg Infect Dis. 2004 Jul;10(7):1321-4 PMID: 15324560
  37. Re-emergence of fatal human influenza A subtype H5N1 disease.
    Lancet. 2004 Feb 21;363(9409):617-9 PMID: 14987888
  38. Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.
    J Virol. 1999 Oct;73(10):8303-7 PMID: 10482580
  39. Avian influenza H5N1 in tigers and leopards.
    Emerg Infect Dis. 2004 Dec;10(12):2189-91 PMID: 15663858
  40. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.
    Vaccine. 2001 Feb 8;19(13-14):1732-7 PMID: 11166898
  41. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997.
    J Infect Dis. 1999 Aug;180(2):505-8 PMID: 10395870
  42. Avian influenza A (H5N1) in 10 patients in Vietnam.
    N Engl J Med. 2004 Mar 18;350(12):1179-88 PMID: 14985470
  43. Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.
    J Virol. 1992 Feb;66(2):1129-38 PMID: 1731092
  44. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
    J Infect Dis. 2005 Apr 15;191(8):1210-5 PMID: 15776364
  45. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene.
    Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1651-6 PMID: 9990079
  46. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology.
    Rev Med Virol. 2000 Mar-Apr;10(2):119-33 PMID: 10713598
  47. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.
    J Virol. 1999 Mar;73(3):2094-8 PMID: 9971791
  48. Human disease from influenza A (H5N1), Thailand, 2004.
    Emerg Infect Dis. 2005 Feb;11(2):201-9 PMID: 15752436
  49. Human and avian influenza viruses target different cell types in cultures of human airway epithelium.
    Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4 PMID: 15070767
  50. The structure and receptor binding properties of the 1918 influenza hemagglutinin.
    Science. 2004 Mar 19;303(5665):1838-42 PMID: 14764886
  51. Confronting the avian influenza threat: vaccine development for a potential pandemic.
    Lancet Infect Dis. 2004 Aug;4(8):499-509 PMID: 15288823
  52. Encephalitis and encephalopathy associated with an influenza epidemic in Japan.
    Clin Infect Dis. 2002 Sep 1;35(5):512-7 PMID: 12173123
  53. H5N1 influenza: a protean pandemic threat.
    Proc Natl Acad Sci U S A. 2004 May 25;101(21):8156-61 PMID: 15148370
  54. Replication of avian influenza A viruses in mammals.
    Infect Immun. 1981 Nov;34(2):354-61 PMID: 7309229
  55. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice.
    J Infect Dis. 1998 Dec;178(6):1592-6 PMID: 9815209
  56. Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9363-7 PMID: 10430948
  57. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.
    Lancet. 2004 Feb 21;363(9409):587-93 PMID: 14987882
  58. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks.
    J Virol. 2004 May;78(9):4892-901 PMID: 15078970
  59. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity.
    Virus Res. 1993 Aug;29(2):155-65 PMID: 8212857
  60. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.
    Nature. 2004 Jul 8;430(6996):209-13 PMID: 15241415
  61. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.
    Science. 1998 Jan 16;279(5349):393-6 PMID: 9430591
  62. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004.
    J Virol. 2005 Aug;79(16):10821-5 PMID: 16051873
  63. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.
    J Infect Dis. 2005 Aug 15;192(4):665-72 PMID: 16028136
  64. Receptor binding properties of human and animal H1 influenza virus isolates.
    Virology. 1989 Nov;173(1):317-22 PMID: 2815586
  65. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma.
    N Engl J Med. 2005 Feb 17;352(7):686-91 PMID: 15716562
  66. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus.
    Nat Rev Microbiol. 2004 Nov;2(11):909-14 PMID: 15494747
  67. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Antiviral Res. 2000 Nov;48(2):101-15 PMID: 11114412
  68. Pathology of fatal human infection associated with avian influenza A H5N1 virus.
    J Med Virol. 2001 Mar;63(3):242-6 PMID: 11170064
  69. Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China.
    J Virol. 2002 Jan;76(1):118-26 PMID: 11739677
  70. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR.
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8950-5 PMID: 12077307
  71. Avian flu: H5N1 virus outbreak in migratory waterfowl.
    Nature. 2005 Jul 14;436(7048):191-2 PMID: 16007072
  72. Containing pandemic influenza at the source.
    Science. 2005 Aug 12;309(5737):1083-7 PMID: 16079251
  73. Evolution and ecology of influenza A viruses.
    Microbiol Rev. 1992 Mar;56(1):152-79 PMID: 1579108
  74. Strategies for containing an emerging influenza pandemic in Southeast Asia.
    Nature. 2005 Sep 8;437(7056):209-14 PMID: 16079797
  75. Avian influenza H5N1 and healthcare workers.
    Emerg Infect Dis. 2005 Jul;11(7):1158-9 PMID: 16032802
  76. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    J Infect Dis. 1999 May;179(5):1132-8 PMID: 10191214
  77. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.
    J Clin Microbiol. 1999 Apr;37(4):937-43 PMID: 10074505
  78. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.
    J Virol. 1989 Nov;63(11):4603-8 PMID: 2795713
  79. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.
    Emerg Infect Dis. 2002 Aug;8(8):796-801 PMID: 12141964
  80. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.
    Clin Infect Dis. 2002 May 1;34 Suppl 2:S58-64 PMID: 11938498
  81. Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice.
    Vet Microbiol. 2003 Aug 29;95(1-2):1-13 PMID: 12860072
  82. The global agenda on influenza surveillance and control.
    Vaccine. 2003 May 1;21(16):1744-8 PMID: 12686087
  83. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.
    Lancet. 2004 Apr 3;363(9415):1099-103 PMID: 15064027
  84. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.
    Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51 PMID: 11226311
  85. On the origin of the human influenza virus subtypes H2N2 and H3N2.
    Virology. 1978 Jun 1;87(1):13-20 PMID: 664248
  86. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
    Nat Rev Microbiol. 2004 Oct;2(10):842-7 PMID: 15378048
  87. Influenza.
    Lancet. 2003 Nov 22;362(9397):1733-45 PMID: 14643124
  88. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.
    Vaccine. 1999 May 4;17(18):2265-74 PMID: 10403594
  89. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
    J Infect Dis. 2005 Apr 15;191(8):1216-20 PMID: 15776365
  90. Initial genetic characterization of the 1918 "Spanish" influenza virus.
    Science. 1997 Mar 21;275(5307):1793-6 PMID: 9065404
  91. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
    Nature. 2004 Oct 7;431(7009):703-7 PMID: 15470432
  92. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.
    J Infect Dis. 1999 Dec;180(6):1763-70 PMID: 10558929
  93. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine).
    Virology. 1997 Jun 9;232(2):345-50 PMID: 9191848
  94. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
    Antimicrob Agents Chemother. 2001 Apr;45(4):1216-24 PMID: 11257037
  95. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004.
    Emerg Infect Dis. 2005 Feb;11(2):210-5 PMID: 15752437
  96. Probable person-to-person transmission of avian influenza A (H5N1).
    N Engl J Med. 2005 Jan 27;352(4):333-40 PMID: 15668219
  97. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41 PMID: 12149435
Article Info
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Abbr.
J Clin Virol
ISSN
1386-6532
DOI
10.1016/j.jcv.2005.09.002
Email
mddejong@hcm.vnn.vn
Published
2006-01-00
Epub
2005-00-06
Pages
2-13
Language
English
Region
Netherlands
NLM ID
9815671
PMCID
PMC7108344
Subset
IM
Grants
Wellcome Trust · United Kingdom
External Links
PubMed source DOI: 10.1016/j.jcv.2005.09.002 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2